The biotechnology company Bio-Works reports preliminary invoicing of SEK 20.0 million for the second quarter of 2026, compared with SEK 13.1 million in the corresponding quarter of the previous year. This is stated in a business update. Invoicing amounted to SEK 49.3 million for the last two quarters, compared with SEK 22.1 million, and to SEK 89.7 million for the last four quarters, compared with SEK 34.6 million. Preliminary order intake for the second quarter amounted to SEK 8.9 million, compared with SEK 27.3 million in the previous year. The order book amounted to SEK 7.0 million as of June 30, 2026. The company reminds that sales and order intake can vary significantly between quarters because the business is still in a growth phase. The board decided, starting from the fourth quarter of 2025, to provide quarterly updates on sales, order book and order intake directly after the end of the quarter.